OTA 2019: No significant difference with bupivacaine injection at surgical site in hip fractures
How to Cite
OrthoEvidence. OTA 2019: No significant difference with bupivacaine injection at surgical site in hip fractures. ACE Report. 2019;8(10):20. Available from: https://myorthoevidene.com/AceReport/Report/12046
A Multicenter Randomized Trial Evaluating Liposomal Bupivacaine for Decrease of Narcotic Use in Hip Fractures
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Hip fractures are very common, and pain management is an issue. Pain itself can cause this pre-disposed population to experience confusion and delirium. On the other hand, opioid medications often used to treat the pain can often have the same effects. Thus, efficacious non-opioid pain management strategies are of great interest in hip fracture patients. The investigators randomized 55 patients to...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE